Compare IRWD & ELVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRWD | ELVR |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 520.6M | 596.4M |
| IPO Year | 2010 | N/A |
| Metric | IRWD | ELVR |
|---|---|---|
| Price | $3.32 | $52.26 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.34 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 81.0K |
| Earning Date | 11-10-2025 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $338,987,000.00 | $146,440,045.00 |
| Revenue This Year | N/A | $22.93 |
| Revenue Next Year | $4.01 | $7.27 |
| P/E Ratio | $19.03 | ★ N/A |
| Revenue Growth | N/A | ★ 11.20 |
| 52 Week Low | $0.53 | $15.55 |
| 52 Week High | $4.78 | $54.95 |
| Indicator | IRWD | ELVR |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | N/A |
| Support Level | $3.11 | N/A |
| Resistance Level | $3.39 | N/A |
| Average True Range (ATR) | 0.20 | 0.00 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 36.36 | 0.00 |
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
Elevra Lithium Ltd is a mineral exploration and development company. The principal activity of the company is the identification, acquisition, and evaluation of mineral exploration assets, focusing on lithium. The projects of the company include the Moblan Lithium Project, the Carolina Lithium Project, the Ewoyaa Lithium Project, North American Lithium, and other projects. The company also holds an interest in a tenement portfolio in the Pilbara region, prospective for gold and lithium.